HELLUMS RHONDA LYNETTE
Insider CIK 1766456 · SLN Chief Financial Officer, Director · PETX CHIEF FINANCIAL OFFICER
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLN Silence Therapeutics plc | A Award deriv | 2026-01-02 | 2026-01-06 | 375,000 | — | $0 | 375,000 | SEC↗ |
| SLN Silence Therapeutics plc | A Award deriv | 2025-01-02 | 2025-01-06 | 375,000 | — | $0 | 375,000 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 25,000 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 67,527 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 15,100 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 14,700 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 2,650 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 6,700 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer deriv | 2019-07-18 | 2019-07-18 | 4,100 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | D To issuer | 2019-07-18 | 2019-07-18 | 51,424 | — | $0 | 0 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award deriv | 2019-02-01 | 2019-02-05 | 67,527 | — | $0 | 67,527 | SEC↗ |
| PETX ARATANA THERAPEUTICS, INC. | A Award | 2019-02-01 | 2019-02-05 | 24,923 | — | $0 | 51,424 | SEC↗ |